tiprankstipranks
Esperion Therapeutics (ESPR)
:ESPR
US Market

Esperion (ESPR) Income Statement

Compare
1,517 Followers

Esperion Income Statement

Last quarter (Q3 2024), Esperion's total revenue was $51.63M, an increase of 52.00% from the same quarter last year. In Q3, Esperion's net income was $-29.52M. See Esperion’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 116.33M$ 75.47M$ 78.45M$ 227.55M$ 148.36M
Gross Profit
$ 73.07M$ 48.51M$ 64.23M$ 225.16M$ -27.25M
Operating Expenses
$ 228.63M$ 228.01M$ 290.96M$ 346.55M$ 241.47M
Depreciation and Amortization
$ 164.00K$ 500.00K$ 612.00K$ 547.00K$ 319.00K
EBITDA
$ -150.11M$ -176.35M$ -222.14M$ -120.33M$ -88.73M
Operating Income
$ -155.56M$ -179.50M$ -226.73M$ -121.40M$ -93.10M
Other Income/Expenses
$ -53.69M$ -54.16M$ -42.38M$ -22.16M$ -4.06M
Pretax Income
$ -209.25M$ -233.66M$ -269.11M$ -143.55M$ -97.17M
Net Income
$ -209.25M$ -287.82M$ -318.82M$ -166.19M$ -109.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.03$ -4.33$ -11.03$ -6.05$ -4.02
Diluted EPS
$ -2.03$ -4.33$ -11.03$ -6.05$ -4.02
Weighted Average Shares Outstanding
103.11M 66.41M 28.90M 27.47M 27.09M
Weighted Average Shares Outstanding (Diluted)
103.11M 66.41M 28.90M 27.47M 27.09M
Currency in USD

Esperion Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis